Gland and Hormone Related Diseases

All Conditions

Neoplasms

Thyroid Diseases

Thyroid Neoplasms

Carcinoma

Carcinoma, Papillary

Endocrine System Diseases

Endocrine Gland Neoplasms

Head and Neck Neoplasms

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Neoplasms, Squamous Cell

Group who will undergo RFA after diagnosis of PTC

Radiofequency ablation for papillary thyroid microcarcinoma will be performed using the system including radiofrequency generator and internally cooled electrode.

RFA for PTMC

Ji-hoon Kim, MD,Ph.D

This is a single center prospective clinical trial with regard to efficacy and safety of radiofrequency ablation of papillary thyroid microcarcinoma.

For treatment of papillary thyroid microcarcinoma (PTMC), radiofrequency ablation (RFA) will be performed with the supine position and neck extended under ultrasonogrphic guidance. Before RFA, local anesthesia will be performed. RFA system including radiofrequency generator (VIVA RF system, STARmed, Goyang-si, Korea) and internally cooled electrode (star RF electrode, STARmed, Goyang-si, Korea) will be used. With regard to RFA procedure, moving shot technique and hydrodissection, if indicated, will be used. After RFA, follow-up will be performed using ultrasonography, serum thyroid function test, and questionnaire for quality of life by face-to-face interview at 2 months, 6, 12, 18, 24 months during the first 2 years after RFA, and yearly afterwards.

Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma

Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma: Safety and Efficacy

Maximal dimension (mm) of ablation zone on Ultrasonography

Cervical Lymph node metastasis on Ultrasonography or other distant metastasis

Score on a Korean version of a thyroid-specific Quality-of-life Questionnaire Scale in Thyroid Cancer Patients

rate of patients who underwent potential side effects from RFA

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma	NCT03432299	Papillary Thyro... Thyroid Cancer	RFA for PTMC	19 Years - 60 Years	Seoul National University Hospital
Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma	NCT03432299	Papillary Thyro... Thyroid Cancer	RFA for PTMC	19 Years - 60 Years	Seoul National University Hospital

Spots Global Cancer Trial Database for rfa for ptmc

Every month we try and update this database with for rfa for ptmc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.